Alopecia: The Search for Novel Agents Continues

    August 1997 in “ Expert Opinion on Therapeutic Patents ”
    Marty E. Sawaya
    Studysummary This review discusses nearly 70 patent applications for the treatment of androgenetic alopecia and other hair conditions, highlighting the mechanisms of action explored but reports no clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 9

    1. An Estrogen Receptor Pathway Regulates the Telogen-Anagen Hair Follicle Transition and Influences Epidermal Cell Proliferation Proceedings of the National Academy of Sciences of the United States of America · 1996
    2. The Antiandrogens Dermatologic Clinics · 1993
    3. Treatment of Female Androgenetic Alopecia with Minoxidil 2% International Journal of Dermatology · 1992
    4. Hair Loss With Minoxidil Withdrawal The Lancet · 1992
    5. The Psychological Effects of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 1992
    6. The Importance of Adequate Serum Ferritin Levels During Oral Cyproterone Acetate and Ethinyl Estradiol Treatment of Diffuse Androgen-Dependent Alopecia in Women Clinical Endocrinology · 1992
    7. The Management of Androgenetic Alopecia in Women Journal of Dermatological Treatment · 1989
    8. Delta 5-3 Beta-Hydroxysteroid Dehydrogenase Activity in Sebaceous Glands of Scalp in Male-Pattern Baldness Journal of Investigative Dermatology · 1988
    9. Adrenal Androgenic Female-Pattern Alopecia: Sex Hormones and the Balding Woman Cleveland Clinic Journal of Medicine · 1983